Malignant Melanoma Archive | Seite 2 von 15 | IOZK

A prospective, randomized, blinded, placebo-controlled, phase IIb trial of an autologous tumor lysate + yeast cell wall particles (YCWP) + dendritic cells (DC) vaccine vs unloaded YCWP + DC and embedded phase I/IIa trial with tumor lysate particle only (TLPO) vaccine in stage III and stage IV (resected) melanoma to prevent recurrence.

2018-01-25/in Dendritic Cells, International Publications, Malignant Melanoma /von 2018-01-25 / J Clin Oncol 36, 2018 (suppl 5S; abstr TPS201)

A phase I vaccination study with dendritic cells loaded with NY-ESO-1 and α-galactosylceramide: induction of polyfunctional T cells in high-risk melanoma patients

2017-11-01/in Dendritic Cells, International Publications, Malignant Melanoma /von 2017-11-01 / Cancer Immunol. Immunother. 2018 02;67(2):285-298

Dendritic cell therapy in melanoma

2017-10-01/in Dendritic Cells, International Publications, Malignant Melanoma /von 2017-10-01 / Ann Transl Med 2017 Oct;5(19):386

Twelve-year survival and immune correlates in dendritic cell-vaccinated melanoma patients

2017-04-20/in Dendritic Cells, International Publications, Malignant Melanoma /von 2017-04-20 / JCI Insight 2017 Apr;2(8)

Immune response and long-term clinical outcome in advanced melanoma patients vaccinated with tumor-mRNA-transfected dendritic cells

2016-10-18/in Dendritic Cells, International Publications, Malignant Melanoma /von 2016-10-18 / Oncoimmunology 2016;5(11):e1232237

Adjuvant Dendritic Cell Vaccination in High-Risk Uveal Melanoma

2016-07-29/in Dendritic Cells, International Publications, Malignant Melanoma /von 2016-07-29 / Ophthalmology 2016 10;123(10):2265-7

Diversification of Antitumour Immunity in a Patient with Metastatic Melanoma Treated with Ipilimumab and an IDO-Silenced Dendritic Cell Vaccine

2016-07-18/in Dendritic Cells, International Publications, Malignant Melanoma /von 2016-07-18 / Case Rep Med 2016;2016:9639585

Dendritic cell vaccination in melanoma patients: From promising results to future perspectives

2016-06-20/in Dendritic Cells, International Publications, Malignant Melanoma /von 2016-06-20 / Hum Vaccin Immunother 2016 10;12(10):2523-2528

5-year follow up for 72 metastatic melanoma patients treated with eltrapuldencel-T (CLBS20) vaccine.

2016-06-05/in Dendritic Cells, International Publications, Malignant Melanoma /von 2016-06-05 / J Clin Oncol 34, 2016 (suppl; abstr 3090)

Adjuvant dendritic cell vaccination induces tumor-specific immune responses in the majority of stage III melanoma patients

2016-05-31/in Dendritic Cells, International Publications, Malignant Melanoma /von 2016-05-31 / Oncoimmunology 2016 Jul;5(7):e1191732